There has been zero production from this plant since 2013. So the closure will not affect availability of medicines in the market.

The decision to close the plant is based on an assessment of its long term viability and its ability to achieve the needed production, it added.
Stating that the closure will not have any effect on the availability of drugs, Pfizer said, "There has practically been no production activity at this plant since 2013, and the closure will not impact the supply of any of the company’s medicines to patients."
Shares of Pfizer Ltd were trading at Rs 2,114.50 per scrip in the afternoon trade on BSE, up 0.18 percent from its previous close.
Source-PTI
MEDINDIA




Email





